Showing 101 - 120 results of 41,667 for search '(( 50 ((((we decrease) OR (teer decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 0.99s Refine Results
  1. 101
  2. 102

    Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

    Published 2014
    “…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”
  3. 103
  4. 104
  5. 105

    Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

    Published 2015
    “…The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. …”
  6. 106

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis.…”
  7. 107
  8. 108
  9. 109

    HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

    Published 2021
    “…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”
  10. 110
  11. 111

    A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

    Published 2015
    “…To test the effects of decreased α1Na,K-ATPase expression on blood pressure, we measured blood pressure by radiotelemetry in three month-old, highly inbred heterozygous knockout <i>ATP1A1+/−</i> male mice with resultant 58% reduction in ATP1A1 protein levels. …”
  12. 112

    Data_Sheet_1_Perceptual Priming Can Increase or Decrease With Aging.PDF by Kalathupiriyan A. Zhivago (9659504)

    Published 2020
    “…To measure implicit perceptual memory, we used a classic perceptual priming paradigm. Participants had to report the shape of a visual search pop-out target whose color or position was varied randomly across trials. …”
  13. 113
  14. 114

    Quantitation of seeding activity in brain tissue from a sporadic CJD patient using end-point RT-QUIC. by Hanae Takatsuki (754161)

    Published 2015
    “…The 5×10<sup>–9</sup> dilution yielded no reaction, as did a negative control consisting of A-CSF. (b) The percentage of positive reaction decreased in a sigmoidal curve within the dilution range when BH was used as the seed. …”
  15. 115
  16. 116

    Effect of specific inhibitors on CYP-mediated CK (50 μM) metabolism in HLMs. by Jian Xiao (253329)

    Published 2016
    “…<p>Note: Furafylline, tranylcypromine, sulfaphenazole, quinidine, chlormethiazole, ticlopidine, and ketoconazole were used as the specific inhibitors for CYP1A2, CYP2A6, CYP2C9, CYP2D6, CYP2E1, and CYP2C19, respectively. …”
  17. 117
  18. 118

    Systemic metabolic switch and glycogen breakdown are required for effective resistance to <i>Streptococcus pneumoniae</i>. by Adam Bajgar (730380)

    Published 2018
    “…(B) Glycogen levels corresponding to measurements in panel A show the decrease of glycogen upon infection (significant differences in 6–24 hpi for <i>ppl x KK</i> control and 15–24 hpi for <i>ppl>GlyP[RNAi]</i>; not marked). …”
  19. 119
  20. 120

    PowerPoint Slides for: Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy by Hwang J.H. (3300987)

    Published 2016
    “…Histologically, group 3 patients were correlated with severe interstitial fibrosis/tubular atrophy (p = 0.004), interstitial inflammation (p = 0.007), hyaline arteriolosclerosis (p = 0.001) and glomerular sclerosis (p < 0.001). A higher initial uPOSTN/Cr level was associated with a greater decline in eGFR during follow-up (p = 0.043 when initial eGFR ≥60; p = 0.025 when eGFR <60 ml/min/1.73 m2), and the renal outcomes with end-stage renal disease (ESRD; p = 0.003), ESRD and/or eGFR decrease of >30% (p = 0.033) and ESRD and/or eGFR decrease of >50% (p = 0.046) occurred significantly more in group 3. …”